|
|
 This is a one-day
conference organized annually by the Southern California Biomedical
Council (SoCalBio) to showcase the
strength and future of the bioscience industry in Los
Angeles/Orange County and neighboring
communities.
This conference will:
-
 Showcase
emerging bioscience firms and technologies looking
for capital and seeking partnerships
-
Offer
keynote presentation and panel discussions to help
entrepreneurs navigate an economy that is both
challenging and changing
-
Highlight
the role of public/private partnerships in
sustaining a regional culture of innovation and
entrepreneurship
-
Explore
new and realistic bioscience commercialization
business models given changes in the economy,
consumer behavior and public policy
-
Create
an environment for rich networking and information
exchange among various bioscience industry
stakeholders
| Keynote |
Alcon's
Peter Richardson Will Keynote the Upcoming SoCalBio Investor
Conference
SoCalBio is pleased to announce that Mr Richardson, who heads
Alcon's clinical and regulatory affairs, will serve as a keynote
speaker during the 14th Annual SocalBio Investor and Partnership
Conference to be held on November 7 at the Omni Hotel in downtown
Los Angeles. Mr. Richardson will talk about partnering for
innovation and provide an overview of Alcon's expanding presrence
in Southern California. Mr. Richardson previously served as Chief
Scientific Office for MannKind Corporation in Valencia and Sr.
Vice President at Novartis. The SoCalBio Investor Conference is a
showcase for emerging biotech and device companies. It will
feature, among other things, over 40 presentations by bioscience
companies seeking funding or partners ... RSVP
to attend
|
Interested in Making a
Presentation During This Conference?
 Device, biotech and health
informatics companies interested in making business presentations during this
event should send non-confidential executive summaries to scbc@socalbio.org.
When summaries are received,
interested firms will be invited to make presentations to the company selection
committee
Selected
companies will be mentored to ensure that their presentations meet the highest
standards required by investors and potential partners.
Click
here for more info | |
|
Who
Should Attend? |
- Biotech, pharma, IVD,
informatics and
medical device company executives
- Venture capitalists
- Angel investors
- Investment bankers
- Life-science educators and
researchers
- Service providers
- Policy makers
- Economic development
professionals
- Media Representatives
|
|
What Did They
Say About Last Year's Conference? |
| "I was very impressed by the SoCalBio
Conference in many ways. First, it was a well- organized and seamless process. I enjoyed the location, the concurrent sessions and the food. More importantly, I liked the select group of professionals, and the companies lined up. It was a great experience and a helpful seminar for
me."
Varaz Shahmirian, Ph.D.
Laursar Technologies (Northridge, CA)
"It was my pleasure to participate in this year's conference. Overall, I was very pleasantly impressed with the conference. The
attendees were a good mix of bio and life-science business folks and service providers. I met lots of people who were either potential clients
or referral sources. I was surprised how many attendees I already knew-- which made the conference more enjoyable. The
sessions that I attended ran smoothly, with good audience attendance and participation."
Mark Benedict, Ph.D.
Knobbe Martens
(Irvine, CA)
| |
WhenYouWish
